Literature DB >> 17412563

Systematic study of association of four GABAergic genes: glutamic acid decarboxylase 1 gene, glutamic acid decarboxylase 2 gene, GABA(B) receptor 1 gene and GABA(A) receptor subunit beta2 gene, with schizophrenia using a universal DNA microarray.

Xu Zhao1, Shengying Qin, Yongyong Shi, Aiping Zhang, Jing Zhang, Li Bian, Chunling Wan, Guoyin Feng, Niufan Gu, Guangqi Zhang, Guang He, Lin He.   

Abstract

Several studies have suggested the dysfunction of the GABAergic system as a risk factor in the pathogenesis of schizophrenia. In the present study, case-control association analysis was conducted in four GABAergic genes: two glutamic acid decarboxylase genes (GAD1 and GAD2), a GABA(A) receptor subunit beta2 gene (GABRB2) and a GABA(B) receptor 1 gene (GABBR1). Using a universal DNA microarray procedure we genotyped a total of 20 SNPs on the above four genes in a study involving 292 patients and 286 controls of Chinese descent. Statistically significant differences were observed in the allelic frequencies of the rs187269C/T polymorphism in the GABRB2 gene (P=0.0450, chi(2)=12.40, OR=1.65) and the -292A/C polymorphism in the GAD1 gene (P=0.0450, chi(2)=14.64 OR=1.77). In addition, using an electrophoretic mobility shift assay (EMSA), we discovered differences in the U251 nuclear protein binding to oligonucleotides representing the -292 SNP on the GAD1 gene, which suggests that the -292C allele has reduced transcription factor binding efficiency compared with the 292A allele. Using the multifactor-dimensionality reduction method (MDR), we found that the interactions among the rs187269C/T polymorphism in the GABRB2 gene, the -243A/G polymorphism in the GAD2 gene and the 27379C/T and 661C/T polymorphisms in the GAD1 gene revealed a significant association with schizophrenia (P<0.001). These findings suggest that the GABRB2 and GAD1 genes alone and the combined effects of the polymorphisms in the four GABAergic system genes may confer susceptibility to the development of schizophrenia in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17412563     DOI: 10.1016/j.schres.2007.02.023

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  20 in total

1.  Genetic modulation of GABA levels in the anterior cingulate cortex by GAD1 and COMT.

Authors:  Stefano Marenco; Antonina A Savostyanova; Jan Willem van der Veen; Matthew Geramita; Alexa Stern; Alan S Barnett; Bhaskar Kolachana; Eugenia Radulescu; Fengyu Zhang; Joseph H Callicott; Richard E Straub; Jun Shen; Daniel R Weinberger
Journal:  Neuropsychopharmacology       Date:  2010-03-31       Impact factor: 7.853

Review 2.  GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.

Authors:  Erik I Charych; Feng Liu; Stephen J Moss; Nicholas J Brandon
Journal:  Neuropharmacology       Date:  2009-07-23       Impact factor: 5.250

3.  Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia.

Authors:  Todd L Edwards; Xu Wang; Qi Chen; Brandon Wormly; Brien Riley; F Anthony O'Neill; Dermot Walsh; Marylyn D Ritchie; Kenneth S Kendler; Xiangning Chen
Journal:  Schizophr Res       Date:  2008-09-18       Impact factor: 4.939

4.  Enlargement of Axo-Somatic Contacts Formed by GAD-Immunoreactive Axon Terminals onto Layer V Pyramidal Neurons in the Medial Prefrontal Cortex of Adolescent Female Mice Is Associated with Suppression of Food Restriction-Evoked Hyperactivity and Resilience to Activity-Based Anorexia.

Authors:  Yi-Wen Chen; Gauri Satish Wable; Tara Gunkali Chowdhury; Chiye Aoki
Journal:  Cereb Cortex       Date:  2015-05-15       Impact factor: 5.357

5.  GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia.

Authors:  R Tao; K N Davis; C Li; J H Shin; Y Gao; A E Jaffe; M C Gondré-Lewis; D R Weinberger; J E Kleinman; T M Hyde
Journal:  Mol Psychiatry       Date:  2017-05-09       Impact factor: 15.992

6.  A novel relationship for schizophrenia, bipolar and major depressive disorder Part 5: a hint from chromosome 5 high density association screen.

Authors:  Xing Chen; Feng Long; Bin Cai; Xiaohong Chen; Gang Chen
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

7.  Deficits in GABA(B) receptor system in schizophrenia and mood disorders: a postmortem study.

Authors:  S Hossein Fatemi; Timothy D Folsom; Paul D Thuras
Journal:  Schizophr Res       Date:  2011-02-08       Impact factor: 4.939

Review 8.  GABA(B) receptors, schizophrenia and sleep dysfunction: a review of the relationship and its potential clinical and therapeutic implications.

Authors:  Joshua Kantrowitz; Leslie Citrome; Daniel Javitt
Journal:  CNS Drugs       Date:  2009-08       Impact factor: 5.749

9.  Genetic variation in GAD1 is associated with cortical thickness in the parahippocampal gyrus.

Authors:  Stefan Brauns; Randy L Gollub; Esther Walton; Johanna Hass; Michael N Smolka; Tonya White; Thomas H Wassink; Vince D Calhoun; Stefan Ehrlich
Journal:  J Psychiatr Res       Date:  2013-04-06       Impact factor: 4.791

10.  Combining gene expression, demographic and clinical data in modeling disease: a case study of bipolar disorder and schizophrenia.

Authors:  Jan Struyf; Seth Dobrin; David Page
Journal:  BMC Genomics       Date:  2008-11-07       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.